Sudha Sundaram

Sudha Sundaram

Auto-generated profile, based on publicly available information

Sudha Sundaram

Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
QPQuang Tien Phan
Quang Tien Phan
WTWen Hui Tan
Wen Hui Tan
RLRanran Liu
Ranran Liu
SSSudha Sundaram
Sudha Sundaram
ABAnita Buettner
Anita Buettner
CWChristoph Winkler
Christoph Winkler
Bone homeostasis requires continuous remodeling of bone matrix to maintain structural integrity. This involves extensive communication between bone-forming osteoblasts and bone-resorbing osteoclasts to orchestrate balanced progenitor cell recruitment and activation. Only a few mediators controlling progenitor activation are known to date and have been targeted for intervention of bone disorders such as osteoporosis. To identify druggable pathways, we generated a medaka (Oryzias latipes) osteoporosis model, where inducible expression of receptor-activator of nuclear factor kappa-Β ligand (Rankl) leads to ectopic formation of osteoclasts and excessive bone resorption, which can be assessed by live imaging. Here we show that upon Rankl induction, osteoblast progenitors up-regulate expression of the chemokine ligand Cxcl9l. Ectopic expression of Cxcl9l recruits mpeg1-positive macrophages to bone matrix and triggers their differentiation into osteoclasts. We also demonstrate that the chemokine receptor Cxcr3.2 is expressed in a distinct subset of macrophages in the aorta-gonad-mesonephros (AGM). Live imaging revealed that upon Rankl induction, Cxcr3.2-positive macrophages get activated, migrate to bone matrix, and differentiate into osteoclasts. Importantly, mutations in cxcr3.2 prevent macrophage recruitment and osteoclast differentiation. Furthermore, Cxcr3.2 inhibition by the chemical antagonists AMG487 and NBI-74330 also reduced osteoclast recruitment and protected bone integrity against osteoporotic insult. Our data identify a mechanism for progenitor recruitment to bone resorption sites and Cxcl9l and Cxcr3.2 as potential druggable regulators of bone homeostasis and osteoporosis. Significance Bone remodeling requires a balanced interplay of osteoblasts and osteoclasts. While the intercellular signaling that triggers bone cell differentiation is well understood, it remains unclear how bone progenitor cells are recruited to remodeling sites. Various chemokines are upregulated under osteoporotic conditions. However, whether they are involved in progenitor recruitment or instead have inflammatory roles is unknown. Here we used a medaka fish osteoporosis model to identify the chemokine ligand Cxcl9l and receptor Cxcr3.2 as essential to control osteoclast progenitor recruitment and differentiation at bone resorption sites. Cxcr3.2 activity can be blocked by small-molecule inhibitors that protect bone from osteoporotic insult. Our study demonstrates the potential of fish for osteoporosis drug discovery and opens avenues for future osteoporosis therapy.

1 November 2019 in Developmental Biology
Verified
Journal Article
Closed access
MDManish Dasyani
Manish Dasyani
WTWen Hui Tan
Wen Hui Tan
SSSudha Sundaram
Sudha Sundaram
NINurgul Imangali
Nurgul Imangali
LCLazaro Centanin
Lazaro Centanin
CWChristoph Winkler
Christoph Winkler

2 March 2018 in Journal of Applied Ichthyology
Verified
Journal Article
Closed access
PDF file
ABA. Buettner
A. Buettner
SSS. Sundaram
S. Sundaram
HVH. Vyas
H. Vyas
TYT. Yu
T. Yu
SMS. Mathavan
S. Mathavan
CWC. Winkler
C. Winkler
Transcriptome profiling of selected cells involved in bone formation, degeneration and repair provides novel insight into mechanisms of bone cell coupling and homeostasis. A medaka osteoporosis model was reported earlier, where excess bone resorption is triggered by induction of receptor activator of nuclear factor κB ligand (RANKL) expression, and bone cell behaviour visualized by live imaging. Herein a protocol for fluorescence‐activated cell sorting (FACS) is described that allows isolation of distinct bone cell types from larvae for subsequent RNA sequencing to detect molecular changes during different phases of bone degeneration and repair.